Macitentan D4 (ACT-064992 D4) 是一种 Macitentan 氘代物。Macitentan (ACT-064992) 是有口服活性，非多肽ETA和ETB(内皮素受体)双拮抗剂。Macitentan 有用于特发性肺纤维化和肺动脉高压的潜力。
。
| 生物活性 | Macitentan D4 (ACT-064992 D4) is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dualETAandETB(endothelin) receptor antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1]. |
| IC50& Target | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 中文名称 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
